Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. The company is headquartered in Redwood City, California and currently employs 55 full-time employees. The company went IPO on 2015-10-26. The firm developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. The company has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.
Follow-Up Questions
Who is the CEO of Biotricity Inc?
Mr. Waqaas Al-Siddiq is the Chairman of the Board of Biotricity Inc, joining the firm since 2016.
What is the price performance of BTCY stock?
The current price of BTCY is $0.6229, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Biotricity Inc?
Biotricity Inc belongs to Health Care industry and the sector is Health Care
What is Biotricity Inc market cap?
Biotricity Inc's current market cap is $16.6M
Is Biotricity Inc a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Biotricity Inc, including 0 strong buy, 0 buy, 3 hold, 1 sell, and 0 strong sell
